EARLY HBEAG LOSS DURING PEGINTERFERON ALPHA-2B THERAPY PREDICTS HBSAG LOSS - RESULTS OF A LONG-TERM FOLLOW-UP STUDY IN CHRONIC HEPATITIS B

被引：0
|
作者：
Buster, Erik H. [1 ]
Flink, Hajo J. [1 ]
Simsek, Halis [2 ]
Heathcote, E. Jenny
Sharmila, Sachithanandan [3 ]
Kitiss, George E. [4 ]
Gerken, Guido [5 ]
Buti, Maria [6 ,7 ]
de Vries, Richard A. [8 ]
Verhey, Elke [1 ]
Hansen, Bettina E. [1 ,9 ]
Janssen, Harry L. [1 ]
机构：
[1] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Hacettepe Univ, Fac Med, TR-06100 Ankara, Turkey
[3] Hosp Selayang, Hepatol Unit, Selangor, Malaysia
[4] George Papanikolaou Gen Reg Hosp, Dept Gastroenterol, Thessaloniki, Greece
[5] Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany
[6] Univ Vall Hebron, Gen Hosp, Liver Unit, Barcelona, Spain
[7] CIBEREHD, Barcelona, Spain
[8] Rijnstate Hosp, Dept Gastroenterol & Hepatol, Arnhem, Netherlands
[9] Erasmus MC Univ Med Ctr, Dept Epidemiol & Biostat, Rotterdam, Netherlands
来源：
HEPATOLOGY | 2008年 / 48卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
928
引用
收藏
页码：723A / 723A
页数：1
相关论文
共 50 条
  • [1] Early HBeAg loss during peginterferon alpha-2b therapy predicts HBsAg loss - results of a long-term follow-up study in chronic hepatitis B
    Buster, E. H. C. J.
    Flink, H. J.
    Simsek, H.
    Heathcote, E. J.
    Sharmila, S.
    Kitis, G. E.
    Gerken, G.
    Buti, M.
    de Vries, R. A.
    Verhey, E.
    Hansen, B. E.
    Janssen, H. L. A.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (03) : A52 - A53
  • [2] Early HBeAg Loss During Peginterferon α-2b Therapy Predicts HBsAg Loss: Results of a Long-Term Follow-Up Study in Chronic Hepatitis B Patients
    Buster, Erik H. C. J.
    Flink, Hajo J.
    Simsek, Halis
    Heathcote, E. Jenny
    Sharmila, Sachithanandan
    Kitis, George E.
    Gerken, Guido
    Buti, Maria
    de Vries, Richard A.
    Verhey, Elke
    Hansen, Bettina E.
    Janssen, Harry L. A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (10): : 2449 - 2457
  • [3] Incidence and Predictors of HBsAg Loss After Peginterferon Therapy in HBeAg-Negative Chronic Hepatitis B: A Multicenter, Long-term Follow-up Study
    Lee, I-Cheng
    Yang, Sien-Sing
    Lee, Chieh-Ju
    Su, Chien-Wei
    Wang, Yuan-Jen
    Lan, Keng-Hsin
    Lin, Han-Chieh
    Hou, Ming-Chih
    Peng, Cheng-Yuan
    Huang, Yi-Hsiang
    JOURNAL OF INFECTIOUS DISEASES, 2018, 218 (07): : 1075 - 1084
  • [4] Sustained HBeAg and HBsAg loss after longterm follow-up of HBeAg positive patients treated with peginterferon alpha-2B
    Buster, Erik H.
    Flink, Hajo J.
    Cakaloglu, Yilmaz
    Simon, Christopher
    Trojan, Joerg
    Tabak, Fehmi
    So, Thomas M.
    Feinman, Victor S.
    Mach, Tomasz
    Akarca, Ulus
    Tielemans, Wanda C.
    van Vuuren, Hanneke J.
    Hansen, Bettina E.
    Janssen, Harry L.
    HEPATOLOGY, 2007, 46 (04) : 667A - 667A
  • [5] Early peginterferon alpha-2b induced HBeAg loss results in increased rates of HBsAg loss and undetectable HBV DNA
    Buster, E. H. C. J.
    van Zonneveld, M.
    Hansen, B. E.
    Verheij, E.
    Janssen, H. L. A.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2007, 19 (10) : A72 - A72
  • [6] Early peginterferon alpha-2B induced HBeAg loss results in increased rates of HBsAg loss and undetectable HBV DNA
    Buster, Erik H.
    van Zonneveld, Monika
    Hansen, Bettina E.
    Verhey, Elke
    Janssen, Harry L.
    HEPATOLOGY, 2006, 44 (04) : 551A - 551A
  • [7] Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon α-2b
    Buster, Erik H. C. J.
    Flink, Hajo J.
    Cakaloglu, Yilmaz
    Simon, Krzysztof
    Trojan, Joerg
    Tabak, Fehmi
    So, Thomas M. K.
    Feinman, S. Victor
    Mach, Tomasz
    Akarca, Ulus S.
    Schutten, Martin
    Tielemans, Wanda
    van Vuuren, Anneke J.
    Hansen, Bettina E.
    Janssen, Harry L. A.
    GASTROENTEROLOGY, 2008, 135 (02) : 459 - 467
  • [8] Long-term follow-up of peginterferon and lamivudine combination treatment in HBeAg-positive chronic hepatitis B
    Chan, HLY
    Hui, AY
    Wong, VWS
    Chim, AML
    Wong, ML
    Sung, JJY
    HEPATOLOGY, 2005, 41 (06) : 1357 - 1364
  • [9] Long-term follow-up of patients treated with entecavir and peginterferon add-on therapy for HBeAg-positive chronic hepatitis B infection: ARES long-term follow-up
    van Campenhout, Margo J. H.
    Brouwer, Willem Pieter
    Xie, Qing
    Guo, S.
    Chi, Heng
    Qi, Xun
    Tabak, Fehmi
    Streinu-Cercel, Adrian
    Wang, Ji-Yao
    Zhang, Ning-Ping
    Idilman, Ramazan
    Reesink, Hendrik W.
    Diculescu, Mircea
    Simon, Krzysztof
    Akdogan, Meral
    Mazur, Wlodzimierz
    de Knegt, Rob J.
    Verhey, Elke
    Hansen, Bettina E.
    Janssen, Harry L. A.
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 (01) : 109 - 117
  • [10] Quantification of HBsAg and HBV-DNA during Therapy with Peginterferon alpha-2b plus Lamivudine and Peginterferon alpha-2b Alone in a German Chronic Hepatitis B Cohort
    Wiegand, J.
    Brosteanu, O.
    Kullig, U.
    Wiese, M.
    Berr, F.
    Maier, M.
    Tillmann, H. L.
    Schiefke, I.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2011, 49 (11): : 1463 - 1469
12345